The current guidelines for hyperlipidemia recommend treatment initiation with statins, followed by a combination of statins and ezetimibe in the second line, and, if the aforementioned strategies fail, the introduction of PCSK-9 inhibitors [15,16]. The gene discussed is PCSK9; the disease is hyperlipidemia.